THANK YOU FOR SUBSCRIBING
There is an increase in the demand for pregnancy health trackers with the increasing application of digital platforms by health care organizations and governments to ensure efficient monitoring of the health status of pregnant women and their children. The market segment is not limited to the personal journal-keeping segment anymore. It increasingly includes remote monitoring, risk screening, appointment follow-up and public health visibility.
The Indian government launched the JANANI initiative in May 2026. This supports continuous digital tracking of maternal and child health services. The government said the platform integrates digital authentication, real-time monitoring and inter-sectoral convergence, ensuring improved service coverage, accountability and maternal-child health outcomes.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
This is important as pregnancy tracking can support both individual care and health-system planning. At the user level, a tool can remind someone about antenatal visits, test schedules or warning signs. At the system level, aggregated service data can help officials see whether pregnant women are receiving care on time.
Furthermore, digital devices have been tailored to facilitate better assessments of the risks involved. According to Mordor Intelligence, Emagine Solutions Technology improved the Journey Pregnancy app in 2025 by using AI technologies that assess the risk of preeclampsia and notify the doctor about the need to follow up on the patient. This points to a shift from passive tracking toward guided risk awareness.
That shift raises the regulatory bar. FDA guidance says the agency applies oversight to certain device software functions and mobile medical applications, especially when software functions present a greater risk to patients if they do not work as intended. A pregnancy tool that moves from wellness education into clinical decision support may face a different regulatory question.
FDA’s Digital Health Policy Navigator also helps developers assess whether a software function meets the medical device definition and whether it may be the focus of FDA oversight. For pregnancy technology companies, this distinction is important before adding features related to risk prediction, diagnosis support or device-connected monitoring.
The remote monitoring process can help in delivering high-risk care services if it is applied correctly. For example, a pregnant woman who may have problems with hypertension, gestational diabetes or recurrent symptoms would require the use of this service as an alert system. Yet the tool must be integrated into the clinical workflow. A warning that no one reviews creates a safety gap.
Challenges to the business include reimbursement and adoption. The health systems require proof that the tool improves outcomes, minimizes missed care or helps with early escalation of cases. Employers and payers may want maternal health benefits, but they will ask whether the tool can demonstrate engagement and care impact.
Anxiety is the human challenge. Pregnancy apps can reassure, but can also make users worry about a lot of symptoms. Providers need careful content design, escalation thresholds and clear instructions on when to contact a clinician.
The next phase of pregnancy health tracking will favor tools that connect personal monitoring with responsible clinical pathways. Features that look impressive in marketing must work safely in real care settings. Pregnancy health monitoring devices are evolving into maternal health monitoring systems. The success of these devices can be gauged by their ability to help the user and the care team recognize problems early.
More in News